pharmaphorum

JANUARY 5, 2023

Nonetheless, Moderna has previously been involved in licensing deals to advance its technology. Stéphane Bancel, chief executive officer at Moderna, said: “With this acquisition, we obtain best-in-class tools for cell-free synthesis and amplification of plasmid DNA, a key building block in mRNA manufacturing.”.

Gene Sequencing 80

Gene Sequencing DNA Vaccination Vaccine 80

pharmaphorum

OCTOBER 1, 2021

.” In its prospectus, Oxford Nanopore said the proceeds from the IPO would be used to increase R&D investment, double its commercial team within the next 18 months, and build up its manufacturing and business development capacity. The post Oxford Nanopore makes stellar debut on UK stock market appeared first on.

Marketing 52

Marketing Genome Genomics Business Development 52

Pharmaceutical Technology

MAY 26, 2023

Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. As per the company, dbDNA is suitable for rapid, scalable manufacture of GMP DNA and can incorporate gene sequences of sizes ranging from 500bp to 20kb, which are typically unstable as pDNA.

DNA 130

DNA Manufacturing Gene Gene Therapy 130

pharmaphorum

FEBRUARY 19, 2021

The injectable single-dose Ebola vaccine is manufactured by MSD, known as Merck & Co in the US and Canada. In November 2019 it was licensed for use by the European Medicines Agency and is now prequalified by WHO, the US FDA, as well as in eight African countries. Novavax has also signed a deal to provide 1.1

Vaccination 65

Vaccination Vaccine Gene Sequencing Manufacturing 65

FDA Law Blog

OCTOBER 24, 2024

Gibbs — A recent blog post focused on the potentially negative implications of the proposed Patent Eligibility Restoration Act (PERA) for manufacturers of generic drugs and biosimilar products. The concerns raised by PERA are not limited to these industries, however.

Gene 64

Gene DNA Genetics Gene Sequencing 64